Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Crosses Below 200-Day Moving Average of $0.69

Northwest Biotherapeutics, Inc. (OTCMKTS:NWBOGet Free Report) crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.69 and traded as low as $0.54. Northwest Biotherapeutics shares last traded at $0.55, with a volume of 987,460 shares trading hands.

Northwest Biotherapeutics Price Performance

The stock has a market cap of $653.81 million, a PE ratio of -9.12 and a beta of -0.68. The business has a fifty day moving average of $0.55 and a 200-day moving average of $0.69.

Northwest Biotherapeutics (OTCMKTS:NWBOGet Free Report) last announced its quarterly earnings results on Tuesday, March 5th. The biotechnology company reported ($0.02) earnings per share (EPS) for the quarter. The company had revenue of $0.45 million during the quarter.

About Northwest Biotherapeutics

(Get Free Report)

Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer.

See Also

Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.